# A new prediction model for acute kidney injury following liver transplantation using grafts from donors after cardiac death

## TL;DR

This study created a machine learning model to predict acute kidney injury after liver transplants using donor grafts from cardiac death patients.

## Contribution

A novel gradient boosting machine model was developed and validated for predicting AKI after liver transplantation with DCD grafts.

## Key findings

- The GBM model achieved an AUC of 0.76 in the testing set and 0.75 in the validation set.
- High preoperative indirect bilirubin and low intraoperative urine output were top predictors of AKI.
- The model helps clinicians identify high-risk patients for timely interventions.

## Abstract

Acute kidney injury (AKI) is a major complication following liver transplantation (LT), which utilizes grafts from donors after cardiac death (DCD). We developed a machine-learning-based model to predict AKI, using data from 894 LT recipients (January 2015–March 2021), split into training and testing sets. Five machine learning algorithms were employed to construct the prediction models using 17 clinical variables. The performance of the models was assessed by the area under the receiver operating characteristic curve (AUC), accuracy, F1-score, sensitivity and specificity. The best-performing model was further validated in an independent cohort of 195 LT recipients who received DCD grafts between April 2021 and December 2021. The Shapley additive explanations method was utilized to elucidate the predictions and identify the most crucial features. The gradient boosting machine (GBM) model demonstrated the highest AUC (0.76, 95% CI: 0.70–0.82), F1-score (0.73, 95% CI: 0.66–0.79) and sensitivity (0.74, 95% CI: 0.66–0.80) in the testing set and a comparable AUC (0.75, 95% CI: 0.67–0.81) in the validation set. The GBM model identified high preoperative indirect bilirubin, low intraoperative urine output, prolonged anesthesia duration, low preoperative platelet count and graft steatosis graded NASH Clinical Research Network 1 and above as the top five important features for predicting AKI following LT using DCD grafts. The GBM model is a reliable and interpretable tool for predicting AKI in recipients of LT using DCD grafts. This model can assist clinicians in identifying patients at high risk and providing timely interventions to prevent or mitigate AKI.